This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Efficacy,Safety and Quality of Life After TOOKAD� ...
Clinical trial

Efficacy,Safety and Quality of Life After TOOKAD� Soluble Vascular Targeted Photodynamic Therapy for Localized Prostate Cancer (PCM304)

Read time: 1 mins
Last updated:1st May 2013

The aim of this study is to confirm the Efficacy,the Safety and the Quality of Life after TOOKAD® Soluble VTP in localized prostate cancer patients.


Study Type: Interventional
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Study of the Efficacy,Safety and Quality of Life After TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Minimally Invasive Treatment of Localized Prostate Cancer
Enrollment: 81
Study Start Date: May 2013
Study Completion Date: March 2015
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
TOOKAD® Soluble

Category Value
Study start date 2013-05-01

View full details